Search Results | Diabetes Care | American Diabetes Association

1-18 of 18

Sort by

Sort Order Select

Journal Articles

Effects of Preceding Ethanol Intake on Glucose Response to Low-Dose Glucagon in Individuals With Type 1 Diabetes: A Randomized, Placebo-Controlled, Crossover Study

Ajenthen Ranjan, Kirsten Nørgaard, Rikke Tetzschner, Isabelle Isa Kristin Steineck, Trine Ryberg Clausen, Jens Juul Holst, Sten Madsbad, Signe Schmidt

Diabetes Care 2018;41(4):797–806

DOI: https://doi.org/10.2337/dc17-1458

Published: 22 January 2018

View article

Includes: Supplementary data

Journal Articles

Low-Carbohydrate Diet Impairs the Effect of Glucagon in the Treatment of Insulin-Induced Mild Hypoglycemia: A Randomized Crossover Study

Ajenthen Ranjan, Signe Schmidt, Camilla Damm-Frydenberg, Isabelle Steineck, Trine Ryberg Clausen, Jens Juul Holst, Sten Madsbad, Kirsten Nørgaard

Diabetes Care 2017;40(1):132–135

DOI: https://doi.org/10.2337/dc16-1472

Published: 21 October 2016

View article

Includes: Supplementary data

Journal Articles

Effects of Liraglutide on Heart Rate and Heart Rate Variability: A Randomized, Double-Blind, Placebo-Controlled Crossover Study

Preman Kumarathurai, Christian Anholm, Bjørn S. Larsen, Rasmus Huan Olsen, Sten Madsbad, Ole Kristiansen, Olav W. Nielsen, Steen B. Haugaard, Ahmad Sajadieh

Diabetes Care 2017;40(1):117–124

DOI: https://doi.org/10.2337/dc16-1580

Published: 19 October 2016

View article

Includes: Supplementary data

Journal Articles

Twelve-Week Treatment With Liraglutide as Add-on to Insulin in Normal-Weight Patients With Poorly Controlled Type 1 Diabetes: A Randomized, Placebo-Controlled, Double-Blind Parallel Study

Christian S. Frandsen, Thomas F. Dejgaard, Jens J. Holst, Henrik U. Andersen, Birger Thorsteinsson, Sten Madsbad

Diabetes Care 2015;38(12):2250–2257

DOI: https://doi.org/10.2337/dc15-1037

Published: 20 October 2015

View article

Includes: Supplementary data

Journal Articles

The Impact of Nocturnal Hypoglycemia on Sleep in Subjects With Type 2 Diabetes

Poul Jennum, Kirstine Stender-Petersen, Rasmus Rabøl, Niklas Rye Jørgensen, Pei-Ling Chu, Sten Madsbad

Diabetes Care 2015;38(11):2151–2157

DOI: https://doi.org/10.2337/dc15-0907

Published: 25 September 2015

View article

Includes: Supplementary data

Journal Articles

Four Weeks of Treatment With Liraglutide Reduces Insulin Dose Without Loss of Glycemic Control in Type 1 Diabetic Patients With and Without Residual β-Cell Function

Urd Kielgast, MD, Thure Krarup, DMSC, Jens Juul Holst, DMSC, Sten Madsbad, DMSC

Diabetes Care 2011;34(7):1463–1468

DOI: https://doi.org/10.2337/dc11-0096

Published: 17 June 2011

View article

Journal Articles

Loss of Incretin Effect Is a Specific, Important, and Early Characteristic of Type 2 Diabetes

Jens J. Holst, MD, Filip K. Knop, MD, Tina Vilsbøll, MD, Thure Krarup, MD, Sten Madsbad, MD

Diabetes Care 2011;34(Supplement_2):S251–S257

DOI: https://doi.org/10.2337/dc11-s227

Published: 22 April 2011

View article

Journal Articles

Postprandial Diabetic Glucose Tolerance Is Normalized by Gastric Bypass Feeding as Opposed to Gastric Feeding and Is Associated With Exaggerated GLP-1 Secretion: A case report

Carsten Dirksen, MD, Dorte L. Hansen, MD, PHD, Sten Madsbad, DMSC, Lisbeth E. Hvolris, MD, Lars S. Naver, MD, Jens J. Holst, DMSC, Dorte Worm, MD, PHD

Diabetes Care 2010;33(2):375–377

DOI: https://doi.org/10.2337/dc09-1374

Published: 16 November 2009

View article

Journal Articles

Incretin-Based Therapies: Viewpoints on the way to consensus

Michael. A. Nauck, MD, Tina Vilsbøll, MD, Baptist Gallwitz, MD, Alan Garber, MD, Sten Madsbad, MD

Diabetes Care 2009;32(suppl_2):S223–S231

DOI: https://doi.org/10.2337/dc09-S315

Published: 01 November 2009

View article

Journal Articles

Liraglutide, a Long-Acting Human Glucagon-Like Peptide-1 Analog, Given as Monotherapy Significantly Improves Glycemic Control and Lowers Body Weight Without Risk of Hypoglycemia in Patients With Type 2 Diabetes

Tina Vilsbøll, MD, DMSC, Milan Zdravkovic, MD, PHD, Tu Le-Thi, MSC, Thure Krarup, MD, DMSC, Ole Schmitz, MD, DMSC, Jean-Pierre Courrèges, MD, Robert Verhoeven, MD, Ingrid Bugánová, MD, Sten Madsbad, MD, DMSC

Diabetes Care 2007;30(6):1608–1610

DOI: https://doi.org/10.2337/dc06-2593

Published: 01 June 2007

View article

Journal Articles

Altered Fat Tissue Distribution in Young Adult Men Who Had Low Birth Weight

Eva Lind Rasmussen, MSC, Charlotte Malis, MSC, Christine Bjørn Jensen, MD, PHD, Jens-Erik Beck Jensen, MD, PHD, Heidi Storgaard, MD, PHD, Pernille Poulsen, MD, PHD, Kasper Pilgaard, MD, Jacob Hagen Schou, MD, Sten Madsbad, MD, DMSC, Arne Astrup, MD, DMSC, Allan Vaag, MD, DMSC, PHD

Diabetes Care 2005;28(1):151–153

DOI: https://doi.org/10.2337/diacare.28.1.151

Published: 01 January 2005

View article

Journal Articles

Additive Effects of Glucagon-Like Peptide 1 and Pioglitazone in Patients With Type 2 Diabetes

Mette Zander, MD, PHD, Allan Christiansen, MD, Sten Madsbad, MD, DMSC, Jens Juul Holst, MD, DMSC

Diabetes Care 2004;27(8):1910–1914

DOI: https://doi.org/10.2337/diacare.27.8.1910

Published: 01 August 2004

View article

Journal Articles

Improved Glycemic Control With No Weight Increase in Patients With Type 2 Diabetes After Once-Daily Treatment With the Long-Acting Glucagon-Like Peptide 1 Analog Liraglutide (NN2211) : A 12-week, double-blind, randomized, controlled trial

Sten Madsbad, MD, DMSC, Ole Schmitz, MD, DMSC, Jonas Ranstam, PHD, Grethe Jakobsen, MSCPHARM, David R. Matthews, DPHIL, FRCP, on behalf of the NN2211-1310 International Study Group

Diabetes Care 2004;27(6):1335–1342

DOI: https://doi.org/10.2337/diacare.27.6.1335

Published: 01 June 2004

View article

Journal Articles

No Hypoglycemia After Subcutaneous Administration of Glucagon-Like Peptide-1 in Lean Type 2 Diabetic Patients and in Patients With Diabetes Secondary to Chronic Pancreatitis

Filip K. Knop, MD, Tina Vilsbøll, MD, Steen Larsen, MD, DMSC, Sten Madsbad, MD, DMSC, Jens J. Holst, MD, DMSC, Thure Krarup, MD, DMSC

Diabetes Care 2003;26(9):2581–2587

DOI: https://doi.org/10.2337/diacare.26.9.2581

Published: 01 September 2003

View article

Journal Articles

Improved Postprandial Glycemic Control With Biphasic Insulin Aspart Relative to Biphasic Insulin Lispro and Biphasic Human Insulin in Patients With Type 2 Diabetes

Kjeld Hermansen, MD, DMSC, Michele Colombo, MD, Heidi Storgaard, MD, Anette Østergaard, MSC PHARM, Klaus Kølendorf, MD, Sten Madsbad, MD

Diabetes Care 2002;25(5):883–888

DOI: https://doi.org/10.2337/diacare.25.5.883

Published: 01 May 2002

View article

Journal Articles

Additive Glucose-Lowering Effects of Glucagon-Like Peptide-1 and Metformin in Type 2 Diabetes

Mette Zander, MD, Mustafa Taskiran, MD, Mai-Britt Toft-Nielsen, MD, Sten Madsbad, MD, PHD, Jens Juul Holst, MD, PHD

Diabetes Care 2001;24(4):720–725

DOI: https://doi.org/10.2337/diacare.24.4.720

Published: 01 April 2001

View article

Journal Articles

Comparison of the Soluble Basal Insulin Analog Insulin Detemir With NPH Insulin: A randomized open crossover trial in type 1 diabetic subjects on basal-bolus therapy

Kjeld Hermansen, MD, Sten Madsbad, MD, Hans Perrild, MD, Allan Kristensen, MSC, Mads Axelsen, MD

Diabetes Care 2001;24(2):296–301

DOI: https://doi.org/10.2337/diacare.24.2.296

Published: 01 February 2001

View article

Journal Articles

Classification of Diabetes in Older Adults

Sten Madsbad, MD

Diabetes Care 1990;13(Supplement_2):93–96

DOI: https://doi.org/10.2337/diacare.13.2.S93

Published: 01 February 1990

View article

NARROW

Effects of Preceding Ethanol Intake on Glucose Response to Low-Dose Glucagon in Individuals With Type 1 Diabetes: A Randomized, Placebo-Controlled, Crossover Study

Low-Carbohydrate Diet Impairs the Effect of Glucagon in the Treatment of Insulin-Induced Mild Hypoglycemia: A Randomized Crossover Study

Effects of Liraglutide on Heart Rate and Heart Rate Variability: A Randomized, Double-Blind, Placebo-Controlled Crossover Study

Twelve-Week Treatment With Liraglutide as Add-on to Insulin in Normal-Weight Patients With Poorly Controlled Type 1 Diabetes: A Randomized, Placebo-Controlled, Double-Blind Parallel Study

The Impact of Nocturnal Hypoglycemia on Sleep in Subjects With Type 2 Diabetes

Four Weeks of Treatment With Liraglutide Reduces Insulin Dose Without Loss of Glycemic Control in Type 1 Diabetic Patients With and Without Residual β-Cell Function

Loss of Incretin Effect Is a Specific, Important, and Early Characteristic of Type 2 Diabetes

Postprandial Diabetic Glucose Tolerance Is Normalized by Gastric Bypass Feeding as Opposed to Gastric Feeding and Is Associated With Exaggerated GLP-1 Secretion: A case report

Incretin-Based Therapies: Viewpoints on the way to consensus

Liraglutide, a Long-Acting Human Glucagon-Like Peptide-1 Analog, Given as Monotherapy Significantly Improves Glycemic Control and Lowers Body Weight Without Risk of Hypoglycemia in Patients With Type 2 Diabetes

Altered Fat Tissue Distribution in Young Adult Men Who Had Low Birth Weight

Additive Effects of Glucagon-Like Peptide 1 and Pioglitazone in Patients With Type 2 Diabetes

Improved Glycemic Control With No Weight Increase in Patients With Type 2 Diabetes After Once-Daily Treatment With the Long-Acting Glucagon-Like Peptide 1 Analog Liraglutide (NN2211) : A 12-week, double-blind, randomized, controlled trial

No Hypoglycemia After Subcutaneous Administration of Glucagon-Like Peptide-1 in Lean Type 2 Diabetic Patients and in Patients With Diabetes Secondary to Chronic Pancreatitis

Improved Postprandial Glycemic Control With Biphasic Insulin Aspart Relative to Biphasic Insulin Lispro and Biphasic Human Insulin in Patients With Type 2 Diabetes

Additive Glucose-Lowering Effects of Glucagon-Like Peptide-1 and Metformin in Type 2 Diabetes

Comparison of the Soluble Basal Insulin Analog Insulin Detemir With NPH Insulin: A randomized open crossover trial in type 1 diabetic subjects on basal-bolus therapy

Classification of Diabetes in Older Adults

Email alerts

Journals

Books

Clinical Compendia

News

Other

About

Resources

Email alerts

Journals

Books

Clinical Compendia

News

Other

About

Resources

This Feature Is Available To Subscribers Only